Congratulations to USC Norris member Dr. Ite Offringa who received a 2024 Mentoring Award for Faculty Mentoring Graduate Students. The USC Mentoring Awards honor faculty who contribute to an engaging, supportive, and inclusive academic environment through their mentorship of

Join us today in commemoration of California HPV Vaccine Week, join this webinar TODAY on HPV vaccination by Dr. Martin Kast at 3 pm PST. Register! #caHPVvaxweek #CaliforniaHPVfree @CAHPVRoundtable USC Norris Comprehensive Cancer Center CaRE2HEC USC Arcadia Hospital American Cancer Society facebook.com/10007557787992…

Moments from White Coat —>🥼 Today our incoming medical students put on their white coats for the first time and began their journey to becoming the future of medicine. #WhiteCoat #WhiteCoatCeremony #WhiteCoat2024 #MedicalSchool #KSOMWhiteCoat

Cancer neuroscientist Josh Neman, PhD, founded the Biomedical Research Apprenticeship Initiative (BRAIN) at USC Norris Comprehensive Cancer Center. The program provides lab training to participants from the Beacon House Association, a rehab program for men. keck.usc.edu/news/usc-brain…

Congratulations to internationally renowned physician-scientist Dr. James Amatruda, member of the USC Norris Translational and Clinical Sciences Program, who has been named Chief of the Division of Hematology-Oncology and Director of the Cancer and Blood Disease Institute (CBDI)

The disruption of gene expression through Polycomb Repressive Complexes 1 and 2 (PRC1 and PRC2), which consists of a group of proteins that serve an essential role in chromatin regulation, is a common occurrence in various human malignancies. Dr. Oliver Bell, member of the USC

This grant, awarded by the Baxter Foundation, seeks to uncover how therapy-induced DNA damage triggers processes that enable glioblastoma tumors to evade treatment, with the goal of finding ways to stop this from happening. Dr. Modrek and his lab team are grateful for this

✨Mariana Stern, PhD, has been appointed as Population and Public Health Sciences at USC Vice Chair of Diversity, Equity, & Inclusion. She looks forward to expanding her ongoing efforts to train the next generation of underrepresented minority public health scholars, & lead efforts to increase diversity (cont'd)⬇️

Congratulations to Dr. Evanthia Roussos Torres, MD, PhD, co-leader of the Tumor Immunology and Microenvironment Program, who received fund from National Cancer Institute to lead a complementary, multi-disciplinary research team to address interdisciplinary research questions at the nexus of cancer health

🌟 Big news! 🌟 @USCNorris, part of Keck Medicine of USC, is opening a new cancer treatment center in Newport Beach in early 2025! 🏥 This location will offer cutting-edge radiation therapy & diagnostic imaging—tech not yet available in Orange County. 🌟 📍 4590 MacArthur Blvd,

Stay Safe this Summer: Know the Facts about #SkinCancer! As we embrace the sunny days of summer, it's crucial to be aware of the risks of skin cancer and how to prevent it. Did you know that skin cancer is the most common type of cancer in the United States? Over 5 million cases

We are pleased to share the July/August 2024 issue of the USC Norris Newsletter, Community for a Cure, which keeps you up to date with everything happening at USC Norris. Click here to read the latest issue: uscnorriscancer.usc.edu/wp-content/upl…

Claradina Soto, PhD, shares the importance of #community involvement in the whole research process when it comes to her work. Read about her latest community-based participatory research initiative: keck.usc.edu/news/ Keck School of Medicine of USC USC Research and Innovation USC Division of Health Behavior Research

Congratulations to USC Norris members Drs. Ricky N. Bluthenthal and Chanita Halbert, who have been appointed as the new interim chair and interim executive vice chair of the Department of Population and Public Health Sciences!   Dr. Bluthenthal is a health behavior researcher and

Increasing numbers of cell and gene therapies are emerging to treat and cure pediatric diseases. However, small market sizes limit the potential return on investment within the traditional biopharmaceutical drug development model, leading to a market failure. In this perspective,

The USC Norris Office of Community Outreach and Engagement recently launched a new campaign titled the Multichannel Communication Campaign for Improvements in Cancer Education and Outcomes (also known as MICEO), as part of our ongoing initiative to increase awareness of the Human

MYC, a group of genes in our DNA that plays a crucial role in controlling how cells grow and divide, is dysregulated in about 70% of human cancers and is the most commonly activated oncoprotein. However, despite recent advances, therapeutic targeting of MYC remains challenging.

September is Childhood Cancer Awareness Month (CCAM) — this month we honor children, survivors and their families and caregivers, who are affected by pediatric cancer. Did you know that: •Approximately 3,427 children in the U.S. are diagnosed with a primary brain tumor every

Congratulations to Jennifer Tsui, Director for Cancer Care Delivery Research and Implementation Science at USC Norris, and USC Norris member Dr. Charité Ricker (she/her/ella) who were selected as two of the USC-DHS Safety Net Innovation Awardees by the Southern California Healthcare Delivery